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An extremely rare case of intrapancreatic bile duct metastasis from sigmoid colon adenocarcinoma is herein
presented. Sigmoid colon cancer (T3, N0, M0, stage IIA) had been diagnosed and treated by sigmoidectomy in
October 1993. In December 2002, a liver metastasis with intrabiliary growth was found, and this was treated by
extended right hepatic lobectomy and caudate lobectomy with extrahepatic bile duct resection. In February
2014, intrapancreatic bile duct metastasis was found, and this was treated by subtotal stomach-preserving
pancreatoduodenectomy. The intrapancreatic metastasis was judged to have arisen from cancer cell implantation,
either by spontaneous shedding of cancer cells or as a complication of percutaneous transhepatic biliary drainage.
Twelve months have passed since the last surgical intervention, and there has been no sign of local recurrence or
distant metastasis. Differential diagnosis between intrahepatic cholangiocarcinoma and intrabiliary growth of a liver
metastasis originating from colorectal adenocarcinoma is difficult but very important for determining the therapeutic
strategy. Careful examination is needed to diagnose intrahepatic biliary dilatation, especially for patients with a history
of carcinoma in the digestive tract and even if years have passed since curative resection of the digestive tract cancer.
Aggressive surgical management for localized recurrence of a hepatic metastasis from colorectal adenocarcinoma may
improve patient survival.
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Intrabiliary growth of a liver metastasis originating from
colorectal carcinoma is a rare manifestation of meta-
static liver carcinoma [1] that resembles intrahepatic
cholangiocarcinoma. Furthermore, intrapancreatic bile
duct metastasis from a colorectal carcinoma is extremely
rare, with few cases having been reported [2, 3]. Herein,
we describe a case of intrabiliary growth of a liver metas-
tasis that arose from a colonic carcinoma and was first
diagnosed as an intrahepatic cholangiocarcinoma and then
as a recurrent colon cancer when, years later, a recurrent
tumor at the intrapancreatic bile duct was discovered,
resected, and analyzed immunohistochemically.* Correspondence: s11357066kwkt@yahoo.co.jp
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A 73-year-old man was examined at our hospital in
February 2014 for a chief complaint of epigastric abdom-
inal pain. Computed tomography (CT) was performed
and clearly depicted a mass with clustered calcifications in
the intrapancreatic bile duct, which was dilated (Fig. 1).
The patient’s medical history, which we describe below,
led to a diagnosis of residual intrapancreatic bile duct
cancer.
The patient had undergone sigmoidectomy in October
1993 for a sigmoid colon cancer, which had the macro-
scopic appearance of a Borrmann type I tumor with a
partial papillary structure and was 2.0 cm in diameter.
Histologic examination of the surgical specimen revealed
a well- to moderately differentiated adenocarcinoma
forming the papillary structure (Fig. 2). The neoplasm
was judged, according to the UICC TNM classification
system, to be a stage IIA tumor that had infiltrated be-
yond the muscularis propria but without lymph noderticle is distributed under the terms of the Creative Commons Attribution
ons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 1 Computed tomography images obtained in February 2014. An obvious mass with clustered calcifications (arrowheads) in the dilated
intrapancreatic bile duct (a) dorsal side (b) ventral side
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formed, and the patient was followed up for 5 years with
no evidence of recurrence. Nine years after the sigmoi-
dectomy, obstructive jaundice developed, and contrast-
enhanced CT revealed dilatation of the intrahepatic bile
duct extending from the posterior segments of the right
lobe to the common hepatic duct and a low-density
mass within the duct (Fig. 3). Intrahepatic cholangiocar-
cinoma was diagnosed. Percutaneous transhepatic biliary
drainage was performed, and this was followed by ex-
tended right hepatic lobectomy and caudate lobectomyFig. 2 Macroscopic and histologic appearances of the sigmoid colon cance
structure was seen in the surgical specimen. b Histologic examination reve
papillary growthwith extrahepatic bile duct resection in December 2002.
Roux-en-Y hepaticojejunostomy was performed, with the
jejunal limb placed in the retrocolic retrogastric position.
Macroscopically, the mass appeared as a papillary lesion
in the posterior segmental bile duct that drains into the
common hepatic duct. Histologic examination revealed a
well-differentiated adenocarcinoma forming an intrabili-
ary papillary tumor and invading the liver at the poster-
ior segmental bile duct that drains into the right hepatic
duct (Fig. 4). Both the proximal and distal margins of
the resected specimen were free of cancer cells. Ther resected in 1993. a A Borrmann type I tumor with a partial papillary
aled a well- to moderately differentiated adenocarcinoma with
Fig. 3 Follow-up contrast-enhanced computed tomography 9 years after sigmoidectomy. CT scans revealed a, b intrahepatic bile duct dilatation
(single arrow) in the posterior segment of the right lobe to the common hepatic duct and c a low-density mass (arrows) in the dilated bile duct.
A schematic diagram (d) shows the tumor location. Bant anterior right hepatic duct, Bpost posterior right hepatic duct, B2 segment 2 bile duct,
B3 segment 3 bile duct, B4 segment 4 bile duct
Fig. 4 Macroscopic and histologic examination of the tumor resected in 2002. Macroscopic examination revealed a, b a papillary lesion
(arrowheads) in the posterior segmental bile duct draining into the common hepatic duct. Arrow indicates the portal vein. Histologic examination
revealed a well-differentiated adenocarcinoma (c) that formed an intrabiliary papillary tumor and invaded the liver at the posterior segmental bile
duct to the right hepatic duct
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tic cholangiocarcinoma (T1, N0, M0).
The patient was followed up regularly after the hepatec-
tomy, and at 2 years and 10 months, contrast-enhanced
CT revealed intrapancreatic bile duct dilatation, but no
cancerous lesion was detected, so the routine follow-up
examinations were continued until February 2014, when
the residual intrapancreatic bile duct cancer was dis-
covered. The discovery was followed by performance of
subtotal stomach-preserving pancreatoduodenectomy in
April 2014. The previous bilio-enteric anastomosis was
preserved (Fig. 5). The operation time was 229 min, and
the blood loss volume was 630 mL. There was no intraop-
erative complication. However, a grade B postoperative
pancreatic fistula (International Study Group on Pancre-
atic Fistula (ISGPF) classification) developed [4], and thus,
the patient’s postoperative hospital stay was 30 days.
Macroscopically, a papillary lesion measuring 70 × 40 mm
was noted in the remnant intrapancreatic bile duct. Histo-
logic examination revealed a well-differentiated adeno-
carcinoma with invasion into the pancreas but no lymph
node metastasis. There was no evidence of lymphatic,
vascular, or perineural invasion (Fig. 6). At this stage,
the tumor was diagnosed as a remnant intrapancreatic
bile duct cancer, but the histologic type, based on
hematoxylin-eosin staining, was identical to that of the
sigmoid colon cancer found in 1993 and the “intrahepatic
cholangiocarcinoma” found in 2002. Furthermore, the
macroscopic types of the three specimens were similar.
Immunohistochemically, the cytokeratin and mucin
core protein expression patterns were similar. All threeFig. 5 Schematic representation of the operative procedure performed in A
b Reconstruction after subtotal stomach-preserving pancreatoduodenectomspecimens were negative for cytokeratin 7 (CK7) and posi-
tive for cytokeratin 20 (CK20) (Fig. 7). This expression
pattern was indicative of metastatic adenocarcinoma,
which most often arises from the colon or rectum [5]. In
addition, neighboring biliary epithelium was CK7-positive
and CK20-negative. All three specimens were weakly posi-
tive for Mucin2 (MUC2) but negative for Mucin1
(MUC1), Mucin5AC (MUC5AC), and Mucin6 (MUC6).
In reviewing the case history, we recalled that a very low-
density mass had been depicted in the intrapancreatic bile
duct in October 2005 and it had gradually enlarged over
several years (Fig. 8). We concluded that the intrabiliary
tumor found in 2002 was a liver metastasis arising from
the sigmoid colon cancer and showing intrabiliary growth
and that the intrapancreatic bile duct tumor originated
from the spontaneous shedding of the biliary tumor
thrombus or from the implantation of tumor cells as a
complication of percutaneous transhepatic biliary drain-
age. Twelve months have passed since the last surgical
intervention, and there has been no sign of local recur-
rence or distant metastasis.
Conclusions
Morphologically, liver metastases from colorectal carcin-
oma usually appear as regular or irregular rounded
masses. Intrabiliary growth of liver metastasis originating
from a colorectal carcinoma is a rare manifestation of
metastatic liver carcinoma [1] that resembles intrahepa-
tic cholangiocarcinoma. There have been several reports
of this type of liver metastasis, which seems to be less
aggressive than usual liver metastasis of colorectalpril 2014. a The dissection lines are marked by two-headed arrows.
y involved preservation of the previous bilio-enteric anastomosis
Fig. 6 Macroscopic and histologic examination of the resected remnant intrapancreatic bile duct. a Macroscopically, a papillary lesion measuring
70 × 40 mm in size existed. b Histologic examination revealed a well-differentiated adenocarcinoma with slight invasion into the pancreas
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recurrence-free survival was significantly longer in cases
of colorectal liver metastasis with macroscopic intrabili-
ary tumor growth than in cases of colorectal liver metas-
tasis without this feature. Likewise, Kubo et al. [7]Fig. 7 Immunohistochemical staining of all three surgical specimens show
(a) was negative for CK7 and positive for CK20. The intrabiliary tumor in 20
negative for CK7 and positive for CK20reported that colorectal liver metastasis showing macro-
scopic intrabiliary extension was less aggressive and had
a better prognosis than that of colorectal liver metastasis
without macroscopic intrabiliary extension. Sugiura et al.
[1] recommended anatomic liver resection for colorectaled similar staining properties. Sigmoid colon cancer resected in 1993
02 (b) and the intrapancreatic bile duct tumor in 2014 (c) were also
Fig. 8 Contrast-enhanced computed tomography revealed the enlargement of the tumor in the intrapancreatic bile duct. CT scans obtained in
a October 2005 (2 years and 10 months after hepatectomy) depicted a very low-density mass in the intrapancreatic bile duct. CT scans obtained
in b December 2007 (5 years after hepatectomy), c January 2011 (8 years and 1 month after hepatectomy), and d February 2014 (11 years and
2 months after hepatectomy) show gradual dilatation of the intrapancreatic bile duct; the mass had gradually enlarged
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the common performance of nonanatomic liver resec-
tion for liver metastasis. An aggressive surgical strategy
may result in improved outcomes in such cases. In our
patient, a remnant intrapancreatic bile duct metastasis
was resected 12 years and 4 months after major hepatec-
tomy with skeletonization of the hepatoduodenal liga-
ment and biliary tract reconstruction was performed.
Intrapancreatic bile duct metastasis from colorectal
carcinoma is rare, with only a few cases reported [2, 3].
Sano et al. [2] described an intrapancreatic bile duct me-
tastasis that was thought to have arisen from cancer cell
implantation; spontaneous shedding of cancer cells may
have occurred. Another possibility was that because the
patient underwent preoperative biliary decompression,
the percutaneous transhepatic biliary drainage (PTBD)
catheter may have grazed the intrabiliary tumor, injured
the biliary mucosa, and caused cancer cell implantation.
The rate of percutaneous transhepatic biliary drainagecatheter tract recurrence has been shown to be signi-
ficantly high in patients treated for cholangiocarcinoma
of the macroscopic papillary type or histologic well-
differentiated adenocarcinoma type [10]. A papillary,
well-differentiated cholangiocarcinoma is thought to be
fragile and quite susceptible to collapse. Although ours
was a case of recurrent colonic cancer rather than
cholangiocarcinoma, the tumor was a papillary, well-
differentiated adenocarcinoma. Thus, we suspected
that the intrapancreatic metastasis had arisen from cancer
cell implantation (via spontaneous shedding or as a com-
plication of PTBD), not from hematogenous intrapancrea-
tic bile duct metastasis.
In such circumstances, the metastasis is not systemic;
it is a local disease. Therefore, in selected patients with
recurrent colorectal cancer, complete surgical resection
may be the best therapeutic option for obtaining a good
outcome. However, the pancreatoduodenectomy we per-
formed after major hepatectomy with skeletonization of
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struction was extremely difficult because of the marked
adhesion caused by the previous operation. Sano et al.
[2] stressed the importance of preserving the previous
bilio-enteric anastomosis in a similar situation. We were
able to preserve the previous bilio-enteric anastomosis,
and we performed subtotal stomach-preserving pancrea-
toduodenectomy with R0 resection. This aggressive sur-
gical approach for the recurrence of intrapancreatic bile
duct metastasis from colon cancer may improve survival,
but it is technically demanding and should be performed
by an experienced hepatobiliary surgical team.
It can be difficult to differentiate between liver metas-
tasis with intrabiliary growth and intrahepatic cholangio-
carcinoma, not only on the basis of preoperative imaging
findings but also on the basis of histologic examination
with hematoxylin-eosin staining. Immunohistochemical
staining proved to be very useful for a precise diagnosis in
our case. The immunohistochemical staining for CK7 and
CK20 was essential to the diagnosis. The effectiveness of
immunohistochemical staining in similar situations has
been reported [11, 12]. Differential diagnosis of a liver
tumor with intrahepatic bile duct dilatation is very import-
ant for determining the therapeutic strategy. Thus, careful
examination is needed to diagnose the intrahepatic biliary
dilatation, especially for patients with a history of car-
cinoma in the digestive tract. In addition, in recognition of
its indolent biologic behavior, long-term postoperative
follow-up should be considered in cases of colorectal liver
metastasis with intrabiliary tumor growth.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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